Nexstim Plc members of the Board Committees

Nexstim Plc, a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that the Board of Directors of Nexstim Plc has decided that Tomas Holmberg shall replace Martin Jamieson in the Remuneration Committee.

Risto Ilmoniemi and Juliet Thompson were elected as new members of the Nomination committee.

After these changes mentioned above the Nexstim Plc Board Committee members are as follows:

  • The chairman of the Audit Committee shall be Juliet Thompson and the members shall be Rohan J. Hoare and Tomas Holmberg.
  • The chairman of the Remuneration committee shall be Ken Charhut and the members shall be Rohan J. Hoare and Tomas Holmberg.
  • The chairman of the Nomination Committee shall be Sami Tuhkanen and the members shall be Risto Ilmoniemi and Juliet Thompson.

You may also like

Manufacturing

Nano CBD: Cannabidiol made with the human body in mind

Infinite CBD's Ali Munk explains how CBD products work, and why choosing nanotechnology as drug delivery increases its bioavailability
Regulatory

GW Pharmaceuticals gains product recognition by NHS England

Epidyolex (cannabidiol) oral solution and Sativex (nabiximols) have been recommended for use by the UK’s National Institute for Health and Care Excellence
Research & Development

AC Immune and Lilly announce licence and collaboration agreement

Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer's disease and other neurodegenerative diseases
Research & Development

Axol Bioscience launches human iPSC-derived microglia

A reproducible, physiologically relevant cellular model of human microglia for neurodegenerative disease drug discovery and development
Research & Development

New approaches to treat psychiatric disorders

Cardiff University forms new drug discovery collaboration for psychiatric disorders
Media

Personalised medication is becoming an increasing possibility for patients

A long sought after objective of healthcare is to ensure that each patient receives tailored treatment for their medical situation
Research & Development

Antiepileptic drugs increase risk of Alzheimer’s and dementia

The use of antiepileptic drugs is associated with an increased risk of Alzheimer’s disease and dementia, according to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE
Subscribe now